Skip to main content
Article thumbnail
Location of Repository

Ten-Year Survival in 75-Year-Old Men and Women: Predictive Ability of Total Cholesterol, HDL-C, and LDL-C

By Göran Nilsson, John Öhrvik, Ingemar Lönnberg and Pär Hedberg


Objective. The purpose of this study was to investigate prognostic impact of cholesterol and its subfractions among 75-year-old people from the general population. Methods and Results. The study comprised a random sample (222 women and 210 men) from the general population (participation rate 70%). During 10-year follow-up, 19% of women and 35% of men experienced a major cardiovascular event (MCVE). The all-cause mortality was 29% for women and 47% for men. After adjustment for cardiovascular risk factors, a low level of high-density lipoprotein cholesterol (HDL-C) was significantly associated with MCVE (P = .006) and mortality (P = .011) in men but not in women. The prognostic sex disparity was nearly significant (P = .051 for MCVE and .067 for mortality). The associations of adjusted HDL-C to MCVE and mortality were unchanged after excluding individuals with prevalent stroke or MI. Total cholesterol and low-density lipoprotein cholesterol (LDL-C) were not significantly related to prognosis in either sex. Main Conclusions. HDL-C was associated with dismal prognosis in men but not in women. Elderly men with HDL-C <40 mg/dL deserve particular attention for cardiovascular prevention

Topics: Clinical Study
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2005). 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice,”
    2. (1988). A b b o t t ,P .W .W i l s o n ,W .B .K a n n e l ,a n dW .P .C a s t e l l i , “High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham study,”
    3. (2004). Aging and HDL metabolism in elderly people more than 100 years old,”
    4. (2006). Apolipoprotein A1 is a strongerprognosticmarkerthanareHDLandLDLcholesterol for cardiovascular disease and mortality
    5. (1995). B y i n g t o n ,J .W .J u k e m a ,J .T .S a l o n e n ,e ta l . ,“ R e d u c t i o n in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program,” Circulation,
    6. (2001). Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study,”
    7. (2007). Cholesterol fractions and apolipoproteins as risk factors for heart disease mortalityinoldermen,”ArchivesofInternalMedicine,vol.167,
    8. (2007). Clinical utility of different lipid measures for prediction of coronary heart disease in men and women,” T h eJ o u rn a lo ft h eA m e ri c a n Medical Association,
    9. (2001). Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a),
    10. (1999). Effect of statins on risk ofcoronarydisease.Ameta-analysisofrandomizedcontrolled trials,”
    11. (2005). Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins,”
    12. (2007). HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events,” The New England
    13. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study,” The AmericanJournalofMedicine,vol.62,no.5,pp.707–714,1977.
    14. (2005). High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies,”
    15. (2004). Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis,”
    16. (1990). Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?”
    17. (1994). Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years,” T h eJ o u r n a lo ft h eA m e r i c a nM e d i c a l Association,
    18. (2001). Left ventricular systolic dysfunction in 75-year-old men and women. A population-based study,”
    19. (2004). Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines,”
    20. (1992). N e a t o n ,H .B l a c k b u r n ,D .J a c o b s ,e ta l . ,“ S e r u mc h o l e s -terol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial,”
    21. (1992). Plasma cholesterol concentration and mortality: the Whitehall Study,”
    22. (1992). Plasma lipids and lipoproteins and the incidence of cardiovascular diseaseintheveryelderly.TheBronxAgingStudy,”Arteriosclerosis and Thrombosis,
    23. (2004). Predictors of falling cholesterol levelsinolderadults:theCardiovascularHealthStudy,”Annals of Epidemiology,
    24. (1998). Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS.
    25. (1998). Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction.
    26. (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study
    27. (2001). report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol
    28. (2007). S.Lewington,G.Whitlock,R.Clarke,etal.,“Bloodcholesterol andvascularmortalitybyage,sex,andbloodpressure:ametaanalysis of individual data from 61 prospective studies with 55,000 vascular deaths,”
    29. (1992). Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316 099 white men,”
    30. Study Collaborative Group, “MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolledtrial,”TheLancet,vol.360,no.9326,pp.7–22,2002.
    31. (2000). t a m l e r ,M .L .D a v i g l u s ,D .B .G a r s i d e
    32. (2007). The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly nondiabetic
    33. (1997). Total cholesterol and risk of mortality in the oldest old,”
    34. (1993). Total serumcholesterollevelsandmortalityriskasafunctionofage: a report based on the Framingham data,”

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.